Olet siirtynyt terveydenhuollon ammattilaisille tarkoitetuille sivuille. Osa sivustoilla olevasta ladattavasta materiaalista on esitetty englannin kielellä. Samoin osa linkkeistä johtaa englanninkielisille jatkosivuille.
ACTIVIA on terveysvaikutteinen jogurtti, joka sisältää ainutlaatuista ACTI REGULARIS® maitohappobakteeria, joka helpottaa ruoansulatusta nautittuna säännöllisesti osana terveellistä ruokavaliota vähintään 14 vrk ajan. Hidas ruoansulatus aiheuttaa monia epämiellyttäviä oireita. ACTIVIA:lla on kliinisesti todistettu teho ruoansulatusajan lyhentämisessä.
Acti Regularis is scientifically proven and clinically tested to survive passage through the digestive tract. It withstands the attacks of strong stomach acids, arriving in the large intestine as a live culture that stays active. This is not the case for many other "live" bacterial cultures which may be destroyed by gastric acids.
 Terveysvaikutukset (.pdf)
Complete monography (.pdf)
Survival of Bifidobacterium lactis DN-173 010, the probiotic strain of Activia through the digestive tract
Survival of Bifidobacterium animalis DN-173 010 in the faecal microbiota after administration in lyophilised form or in fermented product - a randomised study in healthy adults.
Rochet V, L Rigottier-Gois, A Ledaire, C Andrieux, M Sutren, S Rabot, A Mogenet, J-L Bresson, S Cools, C Picard, N Goupil-Feuillerat and J Doré. Journal of Molecular Microbiology and Biotechnology, 2008;14: 128-136.
Effect of yogurt and bifidobacteria supplementation on the colonic microbiota in lactose-intolerant subjects.
He T, M G Priebe, Y Zhong, C Huang, HJM Harmsen, GC Raangs, JM Antoine, GW Welling and RJ Vonk. Journal of Applied Microbiology, 2007; 104(2):595-604.
Molecular detection of Bifidobacterium animalis DN-173 010 in human feces during fermented milk administration.
Collado M.C., Y. Moreno, J.M. Cobo, J.A. Mateos, M. Hernandez. Food Research International, 2006; 39: 530-535
A colony-immunoblotting method for quatitative detection of a Bifidobacterium animalis probiotic strain in human faeces.
Duez H, Pelletier C, Cools S, Aissi E, Cayuela C, Gavini F, Bouquelet S, Neut C and Mengaud J. Journal of Applied Microbiology, 2000; 88:1019-27
Survival of Bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion.
Pochart P, Marteau P, Bouhnik Y, Goderet I, Bourlioux P, Rambaud JC. American Journal of Clinical Nutrition, 1992; 55:78-80
Bifidobacterium from fermented milks: Survival during gastric transit.
Berrada N, Lemeland JF, Laroche G, Thouvenot P, Piaia M. Journal of Dairy Science, 1991; 74:409-413
Isolement des bifidobactéries dans les selles après ingestion prolongée de lait au bifidus (LB).
Pochart P, Marteau P, Bisetti N, Goderet I, Bourlioux P, Rambaud JC. Médecine et Maladies Infectieuses 1990; 20: 75-78 (publication in French)
Activia improves slow digestive transit:
Effect of Bifidobacterium lactis DN-173 010 on the Intestinal Transit Time, the Condition of Defecation and Intestinal Microflora: A randomized, Double-blind, Placebo-controlled, Cross-over Study among Healthy Japanese Women.
Nishida S., Ishikawa Y., Iino H. Pharmacometrics 2008;74 (5/6) : 99-106.
Recent advances in the use of functional foods: effects of the commercial fermented milk with Bifidobacterium animalis strain DN-173 010 and yoghurt strains on gut transit time in the elderly.
Méance S, Cayuela C, Raimondi A, Turchet P, Lucas C and Antoine JM. Microbial Ecology in Health and Disease 2003; 15: 15-22.
Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women : a double blind, randomized, controlled study.
Marteau P, Cuillerier E, Méance S, Gerhardt MF, Myara A, Bouvier M, Bouley C, Tondu F, Bommelaer G, Grimaud JC. Alimentary Pharmacology and Therapeutics, 2002; 16: 587-593.
A fermented milk with a Bifidobacterium probiotic strain DN-173 010 shortened oro-fecal gut transit time in elderly.
Méance S, Cayuela C, Turchet P, Raimondi A, Lucas C and Antoine JM. Microbial Ecology in Health and Disease. 2001; 13: 217-222
Effect of consumption of a milk fermented by the probiotic strain Bifidobacterium animalis DN-173 010 on colonic transit time in healthy humans.
Bouvier M, Méance S, Bouley C, Berta JL and Grimaud JC. Bioscience Microflora. 2001; 20 (2): 43-48.
Additional effect on bowel habits:
Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on Chinese constipated women.
Yang Y., He M., Hu G., Wei J., Pages P., Yang X., Bourdu-Naturel S. World Journal of Gastroenterology, 2008; 14(40): 6237-6243
Activia improves digestive comfort:
Fermented milk containing Bifidobacterium lactis DN-173 010 improved self-reported digestive comfort amongst a general population of adults. A randomized, open-label, controlled, pilot study.
Guyonnet D., Woodcock A., Stefani B., Trevisan C. and Hall C. Journal of Digestive Diseases, 2009; 10: 61-70
Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation.
Agrawal A., Houghton L.A., Morris J., Reilly B.,D., Guyonnet D., Goupil-Feuillerat N., Schlumberger A., Jakob S. & Whorwell P.J.Alimentary Pharmacology and Therapeutics, 2009; 29(1): 104-114.
Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel symdrome adults in primary care. A multicentre, randomised, double-blind, controlled trial.
Guyonnet D, O. Chassany, P. Ducrotte, C. Picard, M. Mouret, C.H. Mercier and C. Matuchansky. Alimentary Pharmacology and Therapeutics, 2007; 26 (3): 475-486.
Fermented milk containing Bifidobacterium lactis DN-173010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study.
Guyonnet D, Schlumberger A, Mhamdi L, Jakob S, Chassany O. British Journal of Nutrition, 2009; July 22:1-9 |
